explores the pharmacological treatment efficacy and safety of various medications used to manage the complex interplay of conditions comprising the syndrome, such as obesity, hypertension, dyslipidemia and insulin resistance. it examines the role of antihypertensive agents, statins and antidiabetic drugs in reducing the cardiovascular risk factors and improving patient outcomes.